Workflow
浙江医药:完成回购1.43%公司股份

Group 1 - The company Zhejiang Medicine announced the completion of a share buyback on August 11, 2025, through the Shanghai Stock Exchange [1] - A total of 13.72 million shares were repurchased, accounting for 1.43% of the company's total share capital [1] - The highest buyback price was 16.09 CNY per share, the lowest was 13.31 CNY per share, and the average buyback price was 14.57 CNY per share, with a total expenditure of approximately 200 million CNY (excluding transaction fees) [1] Group 2 - The repurchased shares will be used for future employee stock ownership plans or equity incentives [1]